Applying competing risks analysis to recurrences of primary breast cancer

被引:0
|
作者
Mancini, Silvia [1 ]
Biggeri, Annibale [2 ]
Giuliani, Orietta [1 ]
Vattiato, Rosa [1 ]
Baldacchini, Flavia [1 ]
Ravaioli, Alessandra [1 ]
Zamagni, Federica [1 ]
Falcini, Fabio [1 ,3 ]
Bucchi, Lauro [1 ]
机构
[1] IRCCS Ist Romagnolo Tumori IRST Dino Amadori, Romagna Canc Inst, Emilia Romagna Canc Registry, Romagna Unit, Forli, Italy
[2] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Unit Biostat Epidemiol & Publ Hlth, Padua, Italy
[3] Local Hlth Author, Canc Prevent Unit, Forli, Italy
来源
EPIDEMIOLOGIA & PREVENZIONE | 2023年 / 47卷 / 06期
关键词
breast cancer; recurrence; competing risks;
D O I
10.19191/EP23.6.A600.084
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: in time-to-event analysis, competing risks are observed when a subject is at risk of multiple types of events. A competing risk is an event that prevents the event of interest from happening or modifies its chance to occur. Objectives: the purposes of this article are to provide an overview of competing risks analysis and to illustrate its application to the follow-up of breast cancer patients in order to estimate the risk of disease recurrence. Design: cohort study. Setting and participants: population-based random sample of patients with stage I-III primary female breast cancer diagnosed in 2000-2013, aged 15 years or older, resident in the Forli health care district ( northern Italy), treated surgically and with available information regarding disease laterality. Main outcome measures: subhazard ratio, hazard ratio and cumulative incidence function for loco-regional recurrences and distant metastasis during 10 years of follow-up. Methods: breast cancer recurrences were evaluated taking into account death from any cause and occurrence of a second primary breast cancer as competing risks. Recent developments in competing risks methodology were used. The results obtained were compared with those from the Cox regression model, in which the competing risks were not accounted for. Conclusions: estimating the risk of recurrence without accounting for the competing risks resulted in a divergence of the hazard/subhazard functions. Competing risks analysis is preferable when the statistical assumption of independence of end-points may be violated.
引用
收藏
页码:363 / 373
页数:11
相关论文
共 50 条
  • [41] Semiparametric competing risks analysis
    Canals-Cerda, Jose
    Gurmu, Shiferaw
    ECONOMETRICS JOURNAL, 2007, 10 (02): : 193 - 215
  • [42] 'That deadly and pink corporeity': Analysis of disease-free survival analysis in breast cancer in Gipuzkoa (Spain) in the presence of competing risks
    Martinez-Camblor, Pablo
    Larranaga, Nerea
    Sarasqueta, Cristina
    Jose Mitxelena, Maria
    Basterretxea, Mikel
    GACETA SANITARIA, 2009, 23 (06) : 554 - 557
  • [43] Second primary cancer risks for female and male breast cancer survivors
    Allen, Isaac
    Rahman, Tameera
    Bacon, Andrew
    Knott, Craig
    Jose, Sophie
    Vernon, Sally
    Hassan, Hend
    Huntley, Catherine
    Loong, Lucy
    Walburga, Yvonne
    Lavelle, Katrina
    Morris, Eva
    Hardy, Steven
    Torr, Beth
    Eccles, Diana
    Turnbull, Clare
    Tischkowitz, Marc
    Pharoah, Paul
    Antoniou, Antonis C.
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Incidence and Patterns of Distant Metastases for Patients With Early-stage Breast Cancer After Breast Conservation Treatment: Competing Risks Analysis
    Milby, A.
    Thukral, A. D.
    Hwang, W.
    Solin, L. J.
    Vapiwala, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S255 - S256
  • [45] Competing approaches to analysis of failure times with competing risks
    Farley, TMM
    Ali, MM
    Slaymaker, E
    STATISTICS IN MEDICINE, 2001, 20 (23) : 3601 - 3610
  • [46] Competing risks of mortality in prostate cancer
    Krongrad, A
    Lai, H
    Lai, SH
    JOURNAL OF UROLOGY, 1997, 158 (03): : 865 - 868
  • [47] Dealing with competing risks in clinical trials: How to choose the primary efficacy analysis?
    Troendle, James F.
    Leifer, Eric S.
    Kunz, Lauren
    STATISTICS IN MEDICINE, 2018, 37 (19) : 2787 - 2796
  • [48] Modelling competing risks in cancer studies
    Klein, JP
    STATISTICS IN MEDICINE, 2006, 25 (06) : 1015 - 1034
  • [49] Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors
    Komoike Y.
    Akiyama F.
    Lino Y.
    Ikeda T.
    Tanaka-Akashi S.
    Ohsumi S.
    Kusama M.
    Sano M.
    Shin E.
    Suemasu K.
    Sonoo H.
    Taguchi T.
    Nishi T.
    Nishimura R.
    Haga S.
    Mise K.
    Kinoshita T.
    Murakami S.
    Yoshimoto M.
    Tsukuma H.
    Inaji H.
    Breast Cancer, 2005, 12 (2) : 104 - 111
  • [50] Competing risks analysis of microsatellite instability as a prognostic factor in colorectal cancer
    Spring, K.
    Toh, J.
    Chapuis, P.
    Bokey, L.
    Chan, C.
    Dent, O.
    ANNALS OF ONCOLOGY, 2018, 29